Sectors

WST
West Pharmaceutical Services, Inc.
358.20
3 x 359.13
1 x 359.49
bid
ask
-
1.50
0.42%
02:35 PM
timesize
Ytd30.19%
1y59.56%
351.56
day range
360.75
210.08
52 week range
365.74
Open356.24Prev Close359.70Low351.56High360.75Mkt Cap25.41B
Vol323.70KAvg Vol854.69KEPS7.97P/E45.13Forward P/E36.95
Beta1.16Short Ratio2.85Inst. Own103.80%Dividend0.88Div Yield0.25
Ex Div Date04-29Earning07-2350-d Avg325.69200-d Avg278.491yr Est365.93
Earning
DateForEstimateReportedSurprisesurprise %
2026-04-232026-031.682.130.4526.79%
2026-02-122025-121.832.040.2111.48%
2025-10-232025-091.671.960.2917.37%
2025-07-242025-061.511.840.3321.85%
2025-04-242025-031.221.450.2318.85%
2025-02-132024-121.751.820.074.00%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-09Morgan StanleyUpgradeEqual-WeightEqual-Weight
2026-07-06Evercore ISI GroupUpgradeOutperformOutperform
2026-07-02KeybancUpgradeOverweightOverweight
2026-06-09BarclaysUpgradeEqual-WeightOverweight
2026-06-02Stephens & Co.UpgradeOverweightOverweight
2026-05-29Morgan StanleyUpgradeEqual-WeightEqual-Weight
Profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Insider Holder
DateNameRelationQuantityDescription
2025-02-17BIRKETT BERNARD JOHNChief Financial Officer7.52KConversion of Exercise of derivative security
2026-05-03BUTHMAN MARK ADirector44.31KStock Award(Grant)
2026-04-26FAVORITE ANNETTE FOfficer21.80KConversion of Exercise of derivative security
2026-05-03FEEHERY WILLIAM F.Director32.52KStock Award(Grant)
2026-02-17GREEN ERIC MARKChief Executive Officer175.42KConversion of Exercise of derivative security
2025-05-05HOFMANN THOMAS WDirector44.64KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Blackrock Inc.6.84M2.42B9.68%
2026-03-30Vanguard Capital Management LLC4.68M1.66B6.63%
2026-03-30Vanguard Portfolio Management LLC4.09M1.45B5.79%
2026-03-30State Street Corporation3.29M1.17B4.66%
2026-03-30Artisan Partners Limited Partnership2.66M940.12M3.76%
2026-03-30Bank Of New York Mellon Corporation2.47M872.20M3.49%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.29M810.71M3.24%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund1.83M646.98M2.59%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund1.56M550.17M2.20%
2026-03-30T. Rowe Price Mid-Cap Growth Fund, Inc.1.06M375.18M1.50%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Growth Index Fund981.39K347.13M1.39%
2026-05-30iShares Trust-iShares Core S&P 500 ETF947.86K335.27M1.34%
Dividend
DividendDate
0.222026-04-29
0.222026-01-28
0.222025-11-12
0.212025-07-30
0.212025-04-30
0.212025-02-07
Split
SplitDate
2 : 12013-09-27
2 : 12004-09-30
2 : 12004-09-29
2 : 11987-06-02
2 : 11982-05-06